HIND: חוב לטווח קצר של החברה Vyome Holdings Inc

The price chart for Vyome Holdings Inc (HIND) reflects the dynamics of a biopharmaceutical business developing unique treatments for fungal skin lesions. The current figure for separate short-term debt stands at 0.00. The company is losing market share in the bandaging segment due to the expansion of injectable weight-loss drugs. Growth prospects rely on combating antibiotic resistance through new anti-inflammatory developments.

This indicator measures the aggregate of all financial obligations of Vyome Holdings Inc (HIND) due within twelve months, allowing for an assessment of the risk of a liquidity gap. By analyzing the volume of short-term debt capital, an investor determines management's ability to fund the development of various antimicrobial therapies, where liquidity control is critical to ensuring the stability of a diversified clinical trial portfolio.